drugset / Trial / NCT00997932

A Pilot Study of Early Postpartum Intrauterine Contraception

NCT00997932

Phase 4 Completed 40 enrolled University of North Carolina, Chapel Hill
NaSingle-groupOpen-labelPrevention

Summary

This is a prospective clinical trial of ultrasound guided intrauterine contraception insertion 10 minutes - 48 hours after vaginal delivery of single infant. A six month follow-up will entail three follow-up visits; 4-6 weeks, 3 months, and 6 months. The objective of this study is to measure intrauterine device (IUD) expulsion and the feasibility of conducting a future clinical trial to evaluate placement of the levonorgestrel-releasing intrauterine contraceptive 10 minutes - 48 hours postpartum.

Timeline

Start
2009-06
Primary completion
2010-10
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule 52 mg Other

Indications

No indication recorded.